Clinical Trials Directory

Trials / Unknown

UnknownNCT01845324

Fetal Heart Interventricular Septum in Fetuses of Diabetic Mothers

Relation Between Fetal Heart Interventricular Septum Size and Gestational Diabetes Mellitus Control. a Prospective Trial

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The investigators asume that the measurement of the fetal heart interventricular septum can serve as a good tool to predict glucose control in pregnant patients with diabetes mellitus. The investigators will measure the septum width in patients with Diabetes and will correlate to standard measurements of the glucuse levels.

Detailed description

In this study the investigators will follow patients with Diabetes Mellitus - mainly gestational. the investigators will measure the width of the interventricular septum and correlate with conventional measures of blood glucose measurements in this population. The investigators will try to assess whether measurement of the septum can be an earlier and better predictor of glucose control in this population.

Conditions

Timeline

Start date
2013-05-01
Primary completion
2014-05-01
Completion
2014-06-01
First posted
2013-05-03
Last updated
2013-05-03

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01845324. Inclusion in this directory is not an endorsement.